Eiger BioPharmaceuticals, Inc., along with its four affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Northern District of Texas on April 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | +6.13% | -13.46% | -66.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.59% | 3.33M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.51% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals, Inc. Filed for Bankruptcy